Luceome Biotechnologies
No Reviews Yet
No Completed Orders
Tucson, Arizona, US
Luceome Biotechnologies is an emerging, privately-held biotechnology company located in Tucson, Arizona. Luceome enables drug discovery by leveraging its assay technology for identification of drugs against kinases.
Luceome provides unique assay solutions (KinaseSeeker™ and KinaseLite™) to clients for... Show more »
Luceome Biotechnologies is an emerging, privately-held biotechnology company located in Tucson, Arizona. Luceome enables drug discovery by leveraging its assay technology for identification of drugs against kinases.
Luceome provides unique assay solutions (KinaseSeeker™ and KinaseLite™) to clients for meeting their selectivity profiling needs as well as for the development of assays against specific targets. Luceome’s assays are based on a technology platform that utilizes luciferase fragment complementation. The resulting luminescence detection is sensitive with low background interference, allowing identification of target and off-target effects of drug candidates.
Available Screening Options:
- Inhibition at single inhibitor dose
- Dose Response Titrations – IC50 Determinations
- Compound Library Screening
- Custom Assay Development
Available Kinase Panels:
- Full-Length Kinase Panel (95 wild-type full length kinases distributed across kinome)
- Tyrosine Kinase Panel (119 wild-type... Show more »
Available Screening Options:
- Inhibition at single inhibitor dose
- Dose Response Titrations – IC50 Determinations
- Compound Library Screening
- Custom Assay Development
Available Kinase Panels:
- Full-Length Kinase Panel (95 wild-type full length kinases distributed across kinome)
- Tyrosine Kinase Panel (119 wild-type kinase-domain and full-length tyrosine kinases)
- Mixed Panel (50 select kinases distributed across kinome)
- Complete Panel of 363 kinases
- A la carte: Pick kinases of your choice and build your own panel
Available Screening Options:
- Inhibition at single inhibitor dose
- Dose Response Titrations – IC50 Determinations
- Compound Library Screening
- Custom Assay Development
Available Kinase Panels:
- Full-Length Kinase Panel (95 wild-type full length kinases distributed across kinome)
- Tyrosine Kinase Panel (119 wild-type... Show more »
Available Screening Options:
- Inhibition at single inhibitor dose
- Dose Response Titrations – IC50 Determinations
- Compound Library Screening
- Custom Assay Development
Available Kinase Panels:
- Full-Length Kinase Panel (95 wild-type full length kinases distributed across kinome)
- Tyrosine Kinase Panel (119 wild-type kinase-domain and full-length tyrosine kinases)
- Mixed Panel (50 select kinases distributed across kinome)
- Complete Panel of 363 kinases
- A la carte: Pick kinases of your choice and build your own panel
Available Screening Options:
- Inhibition at single inhibitor dose
- Dose Response Titrations – IC50 Determinations
- Compound Library Screening
- Custom Assay Development
Available Kinase Panels:
- Full-Length Kinase Panel (95 wild-type full length kinases distributed across kinome)
- Tyrosine Kinase Panel (119 wild-type... Show more »
Available Screening Options:
- Inhibition at single inhibitor dose
- Dose Response Titrations – IC50 Determinations
- Compound Library Screening
- Custom Assay Development
Available Kinase Panels:
- Full-Length Kinase Panel (95 wild-type full length kinases distributed across kinome)
- Tyrosine Kinase Panel (119 wild-type kinase-domain and full-length tyrosine kinases)
- Mixed Panel (50 select kinases distributed across kinome)
- Complete Panel of 363 kinases
- A la carte: Pick kinases of your choice and build your own panel
Luceome provides a custom kinase assay development service to clients who wish to use the luciferase fragment complementation assay for screening inhibitors in-house. We will tailor the assay to fit your profiling needs. Contact us for an initial Feasibility Assessment.
Luceome provides a custom kinase assay development service to clients who wish to use the luciferase fragment complementation assay for screening inhibitors in-house. We will tailor the assay to fit your profiling needs. Contact us for an initial Feasibility Assessment.
Compound Profiling Against Kinases
Available Screening Options:
- Inhibition at single inhibitor dose
- Dose Response Titrations – IC50 Determinations
- Compound Library Screening
- Custom Assay Development
Available Kinase Panels:
- Full-Length Kinase Panel (95 wild-type full length kinases distributed across... Show more »
Compound Profiling Against Kinases
Available Screening Options:
- Inhibition at single inhibitor dose
- Dose Response Titrations – IC50 Determinations
- Compound Library Screening
- Custom Assay Development
Available Kinase Panels:
- Full-Length Kinase Panel (95 wild-type full length kinases distributed across kinome)
- Tyrosine Kinase Panel (119 wild-type kinase-domain and full-length tyrosine kinases)
- Mixed Panel (50 select kinases distributed across kinome)
- Complete Panel of 363 kinases
- A la carte: Pick kinases of your choice and build your own panel
Available Screening Options:
- Inhibition at single inhibitor dose
- Dose Response Titrations – IC50 Determinations
- Compound Library Screening
- Custom Assay Development
Available Kinase Panels:
- Tyrosine Kinase Panel (119 wild-type kinase-domain and full-length tyrosine kinases)
- A la carte: Pick kinases of your choice and build your own panel
Available Screening Options:
- Inhibition at single inhibitor dose
- Dose Response Titrations – IC50 Determinations
- Compound Library Screening
- Custom Assay Development
Available Kinase Panels:
- Tyrosine Kinase Panel (119 wild-type kinase-domain and full-length tyrosine kinases)
- A la carte: Pick kinases of your choice and build your own panel
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to... Show more »
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to high-throughput
- Sensitive: Low Background; Broad dynamic range
- Economical: Contact us to learn about pricing
- Rapid turnaround of data: 7-10 business days
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to... Show more »
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to high-throughput
- Sensitive: Low Background; Broad dynamic range
- Economical: Contact us to learn about pricing
- Rapid turnaround of data: 7-10 business days
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to... Show more »
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to high-throughput
- Sensitive: Low Background; Broad dynamic range
- Economical: Contact us to learn about pricing
- Rapid turnaround of data: 7-10 business days
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to... Show more »
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to high-throughput
- Sensitive: Low Background; Broad dynamic range
- Economical: Contact us to learn about pricing
- Rapid turnaround of data: 7-10 business days
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to... Show more »
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to high-throughput
- Sensitive: Low Background; Broad dynamic range
- Economical: Contact us to learn about pricing
- Rapid turnaround of data: 7-10 business days
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to... Show more »
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to high-throughput
- Sensitive: Low Background; Broad dynamic range
- Economical: Contact us to learn about pricing
- Rapid turnaround of data: 7-10 business days
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to... Show more »
Features and Benefits
- Binding Assay: Identify active site directed as well as allosteric inhibitors
- Luminescence detection: Low false positives from fluorescent compounds
- Cell-free Format: Identify lead compounds in a complex cellular environment at cellular ATP concentrations
- Homogeneous: Portable; Adaptable to high-throughput
- Sensitive: Low Background; Broad dynamic range
- Economical: Contact us to learn about pricing
- Rapid turnaround of data: 7-10 business days
Available Screening Options:
- Inhibition at single inhibitor dose
- Dose Response Titrations – IC50 Determinations
- Compound Library Screening
- Custom Assay Development
Available Kinase Panels:
- Full-Length Kinase Panel (95 wild-type full length kinases distributed across kinome)
- Tyrosine Kinase Panel (119 wild-type... Show more »
Available Screening Options:
- Inhibition at single inhibitor dose
- Dose Response Titrations – IC50 Determinations
- Compound Library Screening
- Custom Assay Development
Available Kinase Panels:
- Full-Length Kinase Panel (95 wild-type full length kinases distributed across kinome)
- Tyrosine Kinase Panel (119 wild-type kinase-domain and full-length tyrosine kinases)
- Mixed Panel (50 select kinases distributed across kinome)
- Complete Panel of 363 kinases
- A la carte: Pick kinases of your choice and build your own panel
Luceome Biotechnologies has not received any reviews.
Luceome Biotechnologies has not received any endorsements.